Live tape
Top 8, mentions 7d28,456NVDA13,491 mentions▲ +0.04ANT4,066 mentions▲ +0.07GOOGL2,885 mentions▲ +0.04SPY2,240 mentions▲ +0.05QQQ1,768 mentions▲ +0.03SPCX1,536 mentions▲ +0.07AMD1,330 mentions▲ +0.06AAPL1,140 mentions▲ +0.04

Equity · Healthcare

AVXL

NASDAQ

Anavex Life Sciences (AVXL)

0.594 USD −12.95% vs prior close Nov 20, 2026
Anavex Life Sciences Corp. price graph
64 sessions
4 0 24 Aug 20 Nov

The line runs 3.11 USD on 24 August through 0.594 USD on 20 November, on a scale from 0 to 4. Days the market did not trade hold the previous close, flat.

Market cap
55.1M USD
EPS, diluted, year to Sep 2025
−0.54 USD
Avg volume
81.5K

as of Nov 20, 2026

Which funds hold Anavex Life Sciences (AVXL)?

7 of the 45 institutional funds we track reported a Anavex Life Sciences position for the quarter ended 30 Sep 2026 — a combined 8.5M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Anavex Life Sciences (AVXL)?
FundPositionSharesValueShares q/q
Two Sigma InvestmentsHeld (±25%)2,336,4204.7M USD−23.3%
Marshall WaceHeld (±25%)758,2381.5M USD−14.8%
Citadel AdvisorsAdded548,8191.1M USD+66.8%
AQR Capital ManagementTrimmed214,266433K USD−77.8%
D. E. Shaw & Co.Added191,638387K USD+66.0%
Renaissance TechnologiesNew position79,999162K USD
Point72 Asset ManagementTrimmed77,502157K USD−50.8%
Millennium ManagementExited
Tudor Investment CorpExited

Have members of Congress traded Anavex Life Sciences (AVXL)?

The most recent congressional trade disclosed in Anavex Life Sciences is a sale by Sara Jacobs (house, CA), dated 12 Dec 2022.

STOCK Act disclosures

Have members of Congress traded Anavex Life Sciences (AVXL)?
TradedMemberTypeAmountFiled after
12 Dec 2022Sara Jacobshouse · Democrat–CASale1K USD–15K USD39 days
12 Oct 2022Sara Jacobshouse · Democrat–CAPurchase1K USD–15K USD35 days

What has been filed or recorded for Anavex Life Sciences (AVXL)?

The filings we hold for Anavex Life Sciences, newest first: 8 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 26 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Anavex Life Sciences (AVXL)?
And
26 Oct 2026Fails to deliverShares failed to deliver5 shares7 USD notional · <0.001% of shares out
22 Oct 2026Fails to deliverShares failed to deliver778 shares1K USD notional · 0.001% of shares out
19 Oct 2026Fails to deliverShares failed to deliver21,210 shares28K USD notional · 0.023% of shares out
15 Oct 2026Fails to deliverShares failed to deliver2,971 shares4K USD notional · 0.003% of shares out
14 Oct 2026Fails to deliverShares failed to deliver1 shares1 USD notional · <0.001% of shares out
13 Oct 2026Fails to deliverShares failed to deliver20,138 shares30K USD notional · 0.022% of shares out
09 Oct 2026Fails to deliverShares failed to deliver21,139 shares33K USD notional · 0.023% of shares out
08 Oct 2026Fails to deliverShares failed to deliver3,356 shares5K USD notional · 0.004% of shares out
30 Jun 2026Quarterly earningsQ3 2026 reportedEPS 0.08 USD
30 Jun 2026FinancialsTotal assets120.1M USDat period end
30 Jun 2026FinancialsTotal equity112.4M USDat period end
31 Mar 2026Quarterly earningsQ2 2026 reportedEPS −0.06 USD
31 Dec 2025Quarterly earningsQ1 2026 reportedEPS −0.06 USD
30 Sep 2025Annual reportFY 2025 reportedEPS −0.54 USD
30 Sep 2025FinancialsNet income−46.4M USDfiscal year
30 Sep 2025FinancialsDiluted EPS−0.54 USDfiscal year
30 Jun 2025Quarterly earningsQ3 2025 reportedEPS −0.16 USD
31 Mar 2025Quarterly earningsQ2 2025 reportedEPS −0.13 USD
31 Dec 2024Quarterly earningsQ1 2025 reportedEPS −0.14 USD
30 Sep 2024Annual reportFY 2024 reportedEPS −0.52 USD

What do people ask about Anavex Life Sciences (AVXL)?

From live data
What did Anavex Life Sciences shares close at?0.594

Anavex Life Sciences closed at 0.594 USD on 20 Nov 2026, down 12.95% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Anavex Life Sciences’ market cap?55.1M

Anavex Life Sciences is worth 55.1M USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

Which funds own Anavex Life Sciences?7 of 45

7 of the 45 funds we track reported a Anavex Life Sciences position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, Marshall Wace and Citadel Advisors. See Funds

Have members of Congress traded Anavex Life Sciences?2 trades

Yes. 2 trades in Anavex Life Sciences appear in the congressional disclosures we hold; the latest is a sale by Sara Jacobs (House, CA) dated 12 Dec 2022, filed 20 Jan 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did Anavex Life Sciences last report earnings?0.08

Anavex Life Sciences last reported earnings on 30 Jun 2026 for Q3 2026, with EPS of 0.08 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGAR13F filings
  4. Wikimedia CommonsPortraits via Wikimedia Commons. Sara Jacobs: Kristie Baxter, Public domain.
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings
  10. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words